# Biosis Healing

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/biosis-healing

- Industry: Healthcare
- Headquarters: Beijing, China
- Website: www.biosishealing.com
- Total disclosed funding: $12M
- Latest round: Series C (Feb 26, 2018)
- Investors on record: 6

## About

Established in 2012, and based in Beijing, China, Biosis Healing is a healthcare company that develops SIS biotechnological materials. The products of the company has acquired permission from FDA 510(k), the Bureau of the U.S. Food and Drug Administration. In December 2018, it closed a series C funding from Sigma Square Capital.

Biosis Healing focuses on developing xenogeneic acellular tissue matrix material products. The products of the company are Wound Repair Matrix, Ligating Clips, Polypropylene Flat mesh, etc. Its products can be used in the fields of Minimally Invasive Surgery, Hernia and Abdominal Wall Surgery, Stomatology, Neurosurgery, and International Business.

The company generates revenue by developing xenogeneic acellular tissue matrix material products.

## Funding rounds

- Series C, Feb 26, 2018 — Sigma Square Capital
- Series B, May 9, 2017 — Qianshan Capital
- Series B, Dec 16, 2016, $12M — MED-FINE Capital, Biossom Investment Management, Proxima Ventures, Dingxin Capital
- Series A, Jan 21, 2016 — Dingxin Capital

## Investors

- Dingxin Capital — Series A, Series B
- MED-FINE Capital (https://capitalatlas.ai/funds/med-fine-capital) — Series B
- Biossom Investment Management (https://capitalatlas.ai/funds/biossom-investment-management) — Series B
- Proxima Ventures (https://capitalatlas.ai/funds/proxima-ventures) — Series B
- Qianshan Capital — Series B
- Sigma Square Capital (https://capitalatlas.ai/funds/sigma-square-capital) — Series C